Determination of flavopiridol (L86 8275; NSC 649890) in human plasma by reversed-phase liquid chromatography with electrochemical detection

Cancer Chemotherapy and Pharmacology

Volumn 42, Issue 4, 1998, Pages 261-265

  Stinson, Sherman F ^a   Hill, Kimberly ^b   Siford, Timothy J ^b   Phillips, Lawrence R ^a   Daw, Tracy W ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

Flavopiridol; HPLC; L86 8275; NSC 649890

Indexed keywords

FLAVOPIRIDOL;

ACCURACY; ARTICLE; CALIBRATION; CASE REPORT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STABILITY; ELECTROCHEMICAL DETECTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TECHNIQUE;

ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLIN-DEPENDENT KINASES; DRUG STABILITY; ELECTROCHEMISTRY; ENZYME INHIBITORS; FLAVONOIDS; HUMANS; HYDROGEN-ION CONCENTRATION; LINEAR MODELS; PIPERIDINES; REPRODUCIBILITY OF RESULTS;

EID: 0031851924     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050815     Document Type: Article

References (8)

1. Carlson BA, Dubay MM, Sausville EA, Worland PJ (1996) Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (cdk 2 and cdk 4 in human breast carcinoma cells. Cancer Res 56: 2973
2. Czech J, Hoffman D, Naik R, Sedlacek H-H (1994) Antitumoral activity of flavone L 86-8275. Int J Oncol 6: 31
3. Kaur G, Stetler-Stevenson M, Sebers S, Worland P, Sedlacek H, Myers C, Czech J, Naik R, Sausville E (1992) Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275. J Natl Cancer Inst 84: 1736
4. Losiewicz MD, Carlson BA, Kaur G, Sausville EA, Worland PJ (1994) Potent inhibition of cdc2 kinase activity by the flavonoid L86-8275. Biochem Biophys Res Commun 201: 589
5. Naik R, Kattige SL, Bhat SV, Alreja B, de Souza NJ, Rupp RH (1988) An antiinflammatory cum immunomodulatory piper-idinylbenzopyranone from Dysoxylum binectariferum. Tetrahedron 44: 2081
6. Sedlacek HH, Czech J, Naik N, Kaur G, Worland P, Losiewicz M, Parker B, Carlson, B, Smith A, Senderowicz A, Sausville E (1996) Flavopiridol (L86 8275; NSC 649890), a new kinase inhibitor for tumor therapy. Int J Oncol 9: 1143
7. Senderowicz AM, Headlee D, Stinson S, Lush RM, Figg WD, Pluda J, Sausville EA (1997) A phase I trial of flavopiridol (FLA), a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms. Proc Am Soc Clin Oncol 16: 226A #793 (Abstract)
8. cdc2 kinase by the flavone L86-8275 in breast carcinoma cells. Biochem Pharmacol 46: 1831